Last reviewed · How we verify

NCT03271463

Assessing Leg Control in People With Chronic Stroke

Completed Last updated 14 April 2021
What this trial tests

trial testing Selective Control Assessment of Lower Extremity (SCALE) in Chronic Stroke in 16 participants. Completed in 5 November 2020.

Timeline
5 August 2018
Primary endpoint
5 November 2020
5 November 2020

Quick facts

Lead sponsorUniversity of Minnesota
StatusCompleted
Study typeOBSERVATIONAL
Enrollment16
Start date5 August 2018
Primary completion5 November 2020
Estimated completion5 November 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Minnesota

Who can join

Adults 18 to 79, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the clinometric (psychometric) properties of the SCALE and FMA-LE assessments in adults after stroke. A second purpose is to determine how well each measure predicts walking speed using the 10 meter walk test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other University of Minnesota trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03271463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing